3Villanacci V;Grigolato PG;Cestari R.Dilated intercellular spaces as markers of reflux disease:histology,semiquantitative score and morphometry upon light microscopy[J],2001.
4Fass R;Ofman JJ.Gastroesophageal reflux disease: should we adopt a new conceptual framework?,2002.
5Micheal FV.Ear, nose, and throat manifestations of gastroesophageal reflux disease,2002.
6Siupsinskiene N;Adamonis K.Diagnosis test with omeprazole in patients with posterior laryngitis,2003.
7Sharma P;Weston AP;Topalovski M.Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett′s oesophagus[J],2003.
8Ours TM;Fackler WK;Richter JE.Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure[J],2003(3).
9Yagi K;Nakamura A;Sekine A.Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett′s esophagus in Japanese patients without Helicobacter pylori infection[J],2003.
2Shaw MJ, Talley N J, P, eebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol, 2001, 96:52-57.
3DeVault KR, Castell DO. Updated guidelines for diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol,1999,94: 1434-1442.
4Carlsson R, Dent J, Bolling-Sternevald E,et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol, 1998, 33: 1023-1029.
5Swets JA. Measuring the accuracy of diagnostic systems. Sciences,1988, 240 : 1285.